Cargando…

Differential Expression of MicroRNAs in Silent and Functioning Corticotroph Tumors

The potential role of miRNAs in the silencing mechanisms of pituitary neuroendocrine tumors (PitNETs) has not been addressed. The aim of the present study was to evaluate the expression levels and the potential associated role of some miRNAs, pathways, and transcription factors in the silencing mech...

Descripción completa

Detalles Bibliográficos
Autores principales:	García-Martínez, Araceli, Fuentes-Fayos, Antonio C., Fajardo, Carmen, Lamas, Cristina, Cámara, Rosa, López-Muñoz, Beatriz, Aranda, Ignacio, Luque, Raúl M., Picó, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355784/ https://www.ncbi.nlm.nih.gov/pubmed/32545591 http://dx.doi.org/10.3390/jcm9061838

Ejemplares similares

Increased E2F1 mRNA and miR-17-5p Expression Is Correlated to Invasiveness and Proliferation of Pituitary Neuroendocrine Tumours
por: García-Martínez, Araceli, et al.
Publicado: (2020)

A Silent Corticotroph Pituitary Carcinoma: Lessons From an Exceptional Case Report
por: Remón-Ruiz, Pablo, et al.
Publicado: (2021)

A Case of Silent Corticotroph Adenoma
por: Ibekwe, Usonwanne U, et al.
Publicado: (2021)

Is it time to consider the expression of specific-pituitary hormone genes when typifying pituitary tumours?
por: García-Martínez, Araceli, et al.
Publicado: (2018)

MON-469 Pituitary Corticotroph Lesions: Clinical, Biochemical, and Pathological Characterization of Cushing Disease, Silent Corticotroph Adenomas, and Corticotroph Hyperplasia
por: Castlen, Joseph, et al.
Publicado: (2019)

ODP312 Giant Silent Corticotroph Adenoma: Presentation of 3 Cases
por: Oliveira, Miriam C, et al.
Publicado: (2022)

How Valuable Is the RT-qPCR of Pituitary-Specific Transcription Factors for Identifying Pituitary Neuroendocrine Tumor Subtypes According to the New WHO 2017 Criteria?
por: Torregrosa-Quesada, María Eugenia, et al.
Publicado: (2019)

Clinical Significance of Radical Surgery in the Treatment of Silent Corticotroph Adenoma
por: Kim, Junhyung, et al.
Publicado: (2019)

LBODP079 A Case of Silent Invasive Corticotroph Adenoma
por: Bendaram, Snigdha Reddy, et al.
Publicado: (2022)

Contribution of molecular analysis to the typification of the non-functioning pituitary adenomas
por: Sanchez-Tejada, Laura, et al.
Publicado: (2017)

Silent Corticotroph Tumor with Adrenocortical Choristoma in an Eleven-year-old Boy
por: Turan, Hande, et al.
Publicado: (2022)

An Update on Silent Corticotroph Adenomas: Diagnosis, Mechanisms, Clinical Features, and Management
por: Jiang, Shenzhong, et al.
Publicado: (2021)

Silent Crooke’s cell corticotroph adenoma of the pituitary gland presenting as delayed puberty
por: Giri, Dinesh, et al.
Publicado: (2017)

The Genomic Landscape of Corticotroph Tumors: From Silent Adenomas to ACTH-Secreting Carcinomas
por: Andonegui-Elguera, Sergio, et al.
Publicado: (2022)

A novel human tumoroid 3D model of sustained ACTH-secreting cell cultures to study critically needed therapies for Cushing's disease
por: Fuentes-Fayos, Antonio C., et al.
Publicado: (2021)

SAT-LB57 The Spectrum of Genomic and Transcriptomic Alterations in ACTH-Producing and ACTH-Silent Corticotroph Adenomas
por: Lerario, Antonio Marcondes, et al.
Publicado: (2020)

Neurocysticercosis, Meningioma, and Silent Corticotroph Pituitary Adenoma in a 61-Year-Old Woman
por: Ramirez, Maria del Pilar, et al.
Publicado: (2012)

Postoperative expression of Cushing disease in a young male: metamorphosis of silent corticotroph adenoma?
por: Jahan, Sharmin, et al.
Publicado: (2019)

SST5 expression and USP8 mutation in functioning and silent corticotroph pituitary tumors
por: Castellnou, Solène, et al.
Publicado: (2020)

New Transcriptional Insights into Silent and Active Corticotroph Pituitary Tumors at Single Cell Resolution
por: Zhang, Dongyun, et al.
Publicado: (2021)

Silent Corticotroph and Somatotroph Double Pituitary Adenoma: A Case Report and Review of Literature
por: Pecorari, Isabella L., et al.
Publicado: (2022)

PMON122 Unveiling the Kraken- An Incidentally Found Silent Corticotroph Adenoma of the Pituitary Gland
por: Shteyman, Sara, et al.
Publicado: (2022)

ODP351 Silent Corticotroph Adenomas – Characteristics and Comparisons to Other Non-functioning Pituitary Adenomas: A Case Series
por: Di Ieva, Antonio, et al.
Publicado: (2022)

The expression of glucocorticoid and mineralocorticoid receptors in pituitary tumors causing Cushing’s disease and silent corticotroph tumors
por: Kober, Paulina, et al.
Publicado: (2023)

A silent corticotroph adenoma: making the case for a pars intermedia origin. Illustrative case
por: Alsavaf, Mohammad Bilal, et al.
Publicado: (2023)

Case Report: Progression of a Silent Corticotroph Tumor to an Aggressive Secreting Corticotroph Tumor, Treated by Temozolomide. Changes in the Clinic, the Pathology, and the β-Catenin and α-SMA Expression
por: Demarchi, Gianina, et al.
Publicado: (2022)

OR23-04 SST5 Expression and USP8 Mutation in Functioning and Silent Corticotroph Pituitary Tumors
por: castellnou, Solene, et al.
Publicado: (2020)

Highly Aggressive and Radiation-Resistant, “Atypical” and Silent Pituitary Corticotrophic Carcinoma: A Case Report and Review of the Literature
por: Flores, Laura, et al.
Publicado: (2019)

Distinct Pattern of Endoplasmic Reticulum Protein Processing and Extracellular Matrix Proteins in Functioning and Silent Corticotroph Pituitary Adenomas
por: Eieland, Alexander K., et al.
Publicado: (2020)

Refractory corticotroph adenomas
por: Sumal, Amit K. S., et al.
Publicado: (2023)

Quantitative Ubiquitinomics Revealed Abnormal Ubiquitinated ATP7A Involved in Down-Regulation of ACTH in Silent Corticotroph Adenomas
por: Zhao, Sida, et al.
Publicado: (2022)

Difference in miRNA Expression in Functioning and Silent Corticotroph Pituitary Adenomas Indicates the Role of miRNA in the Regulation of Corticosteroid Receptors
por: Mossakowska, Beata J., et al.
Publicado: (2022)

Aggressive corticotroph tumors and carcinomas
por: Lasolle, Hélène, et al.
Publicado: (2022)

Clinical, Laboratory, and Treatment Profiles of Silent Corticotroph Adenomas That Have Transformed to the Functional Type: A Case Series With a Literature Review
por: Zheng, Guangyao, et al.
Publicado: (2020)

Pituitary Cachexia Treated with Corticotrophic Hormone
por: Hemphill, R. E.
Publicado: (1946)

Sex differences in pituitary corticotroph excitability
por: Duncan, Peter J., et al.
Publicado: (2023)

Clinical Parameters of Silent Corticotroph Adenomas With Positive and Negative Adrenocorticotropic Hormone Immunostaining: A Large Retrospective Single-Center Study of 105 Cases
por: Zhang, Keyi, et al.
Publicado: (2021)

THU099 The Challenging Management Of Silent Corticotroph PitNET—From Very Aggressive To Mild Course Of Disease During Long Follow Up
por: Bogusławska, Anna, et al.
Publicado: (2023)

Differentiation of silent corticotroph pituitary neuroendocrine tumors (PitNETs) from non-functioning PitNETs using kinetic analysis of dynamic MRI
por: Amano, Taishi, et al.
Publicado: (2023)

MON-309 Prevalence of Silent Corticotroph Adenomas in a Large Cohort of Nonfunctioning Pituitary Adenomas: Plasma Proopiomelanocortin(POMC) Levels and Response to Pasireotide LAR
por: Reyes-Vidal, Carlos, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_taich58kni1fa3npfblc5bob4o